CO5611139A2 - Pirimidinas aril sustituidas y el uso de las mismas - Google Patents
Pirimidinas aril sustituidas y el uso de las mismasInfo
- Publication number
- CO5611139A2 CO5611139A2 CO04101907A CO04101907A CO5611139A2 CO 5611139 A2 CO5611139 A2 CO 5611139A2 CO 04101907 A CO04101907 A CO 04101907A CO 04101907 A CO04101907 A CO 04101907A CO 5611139 A2 CO5611139 A2 CO 5611139A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- hydrogen
- alkoxy
- link
- alkyloxyalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1.- Un compuesto de fórmula 1: o una sal farmacéuticamente aceptable, o solvato de estos, en donde:A se selecciona de C=O o C-R4; en donde:Cuando A es C=O, el enlace entre N y A es un enlace sencillo y R3 está presente;Cuando A es C-R4, el enlace entre N y A es un enlace doble y R3 no está presente; yR4 es hidrógeno, alquilo C1-6, alcoxi C1-6, haloalquilo C1-6 hidroxialquilo C1-6 o alquiloxialquilo C1-6;R1 se selecciona a partir del grupo que consiste de:(i) Fenoxifenilo;(ii) Benziloxifenili;(iii) Fenitiofenilo; (iv) Benziltiofenilo;(v) Fenilo;(vi) NaftaleniloEn donde el anillo arilo terminal de cada uno de (i) a (iv), y cualquier parte del anillo (v) y (vi) son opcionalmente sustituidos mediante uno o más de: halógeno, alquilo C1-6, alcoxi C1-6, Haloalquilo C1-6 hidroxialquilo C1-6 o alquiloxialquilo C1-6; con la condición de que cuando: (a) R1 es fenilo y A es C-R4 donde R4 es hidrógeno o alquilo C1-6; R2 no es:(i) hidrógen;(ii) Alquilo C1-3;(iii) Benzilo alcoxi sustituido (iv) Alquiloxialquilo C1-2;(v) Hidroxialquilo C1-2;(vi) Haloalquilo C1-2;(vii) Alcoxi C1-3; o cuando:(b) R1 es fenilo y A es C=O; R2 no es hidrógeno; o cuando:(c) R1 es naftalenilo y A es C-R4, donde R4 es hidrógeno o alquilo C1-6;R2 no es (i) hidrógeno o (ii) Alquilo C1-6; ...
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36354402P | 2002-03-13 | 2002-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5611139A2 true CO5611139A2 (es) | 2006-02-28 |
Family
ID=27805282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04101907A CO5611139A2 (es) | 2002-03-13 | 2004-10-12 | Pirimidinas aril sustituidas y el uso de las mismas |
Country Status (27)
Country | Link |
---|---|
US (1) | US7229993B2 (es) |
EP (1) | EP1483247B1 (es) |
JP (1) | JP4473583B2 (es) |
KR (1) | KR20040099324A (es) |
CN (1) | CN1646500A (es) |
AP (1) | AP2004003152A0 (es) |
AT (1) | ATE434610T1 (es) |
AU (1) | AU2003223049A1 (es) |
BR (1) | BR0308451A (es) |
CA (1) | CA2479036A1 (es) |
CO (1) | CO5611139A2 (es) |
CR (1) | CR7526A (es) |
CY (1) | CY1109355T1 (es) |
DE (1) | DE60328087D1 (es) |
DK (1) | DK1483247T3 (es) |
EA (1) | EA200401120A1 (es) |
EC (1) | ECSP045360A (es) |
ES (1) | ES2328471T3 (es) |
IL (1) | IL163940A0 (es) |
IS (1) | IS7468A (es) |
MA (1) | MA27196A1 (es) |
MX (1) | MXPA04008901A (es) |
NO (1) | NO20044311L (es) |
PT (1) | PT1483247E (es) |
SI (1) | SI1483247T1 (es) |
TN (1) | TNSN04174A1 (es) |
WO (1) | WO2003076414A2 (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004538285A (ja) * | 2001-07-16 | 2004-12-24 | ユーロ−セルティック エス. ア. | アリール置換チアゾリジノンおよびその使用 |
AR037233A1 (es) * | 2001-09-07 | 2004-11-03 | Euro Celtique Sa | Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento |
EP1532119A2 (en) * | 2002-07-31 | 2005-05-25 | Euro-Celtique S.A. | Aryl substituted benzimidazoles and their use as sodium channel blockers |
US20040152696A1 (en) * | 2002-08-01 | 2004-08-05 | Euro-Celtique S.A. | 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers |
US20050227974A9 (en) * | 2002-08-01 | 2005-10-13 | Euro-Celtique S.A. | Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers |
US7790734B2 (en) * | 2003-09-08 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
EP2522670A1 (en) | 2004-04-07 | 2012-11-14 | Takeda Pharmaceutical Company Limited | Heterocyclic CRF receptor antagonists |
US20070135437A1 (en) * | 2005-03-04 | 2007-06-14 | Alsgen, Inc. | Modulation of neurodegenerative diseases |
ES2340708T3 (es) * | 2005-03-04 | 2010-06-08 | Alsgen, Inc. | Tratamiento de esclerosis lateral amiotrofica con pirimetamina y analogos. |
ME02005B (me) | 2005-09-14 | 2012-08-31 | Takeda Pharmaceuticals Co | Inhibitori dipeptidil peptidaze za lečenje dijabetesa |
CN101360723A (zh) | 2005-09-16 | 2009-02-04 | 武田药品工业株式会社 | 制备嘧啶二酮衍生物的方法 |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
EP2593434A1 (en) | 2010-07-16 | 2013-05-22 | Purdue Pharma LP | Pyridine compounds as sodium channel blockers |
CN103153955A (zh) | 2010-09-17 | 2013-06-12 | 普渡制药公司 | 吡啶化合物及其用途 |
US9045435B2 (en) | 2010-10-05 | 2015-06-02 | Purdue Pharma, L.P. | Quinazoline compounds as sodium channel blockers |
KR20130119964A (ko) | 2010-12-22 | 2013-11-01 | 퍼듀 퍼머 엘피 | 나트륨 채널 차단제로서의 치환된 피리딘 |
AU2012300567B2 (en) | 2011-09-02 | 2016-03-10 | Purdue Pharma L.P. | Pyrimidines as sodium channel blockers |
AU2012321111A1 (en) | 2011-10-31 | 2013-05-16 | Purdue Pharma L.P. | Quaternized amines as sodium channel blockers |
US9181185B2 (en) | 2011-10-31 | 2015-11-10 | Purdue Pharma L.P. | Heteroaryl compounds as sodium channel blockers |
WO2013072758A1 (en) | 2011-11-15 | 2013-05-23 | Purdue Pharma L.P. | Pyrimidine diol amides as sodium channel blockers |
US9206127B2 (en) | 2012-03-16 | 2015-12-08 | Purdue Pharm, L.P. | Substituted pyridines as sodium channel blockers |
US9714252B2 (en) | 2012-12-20 | 2017-07-25 | Purdue Pharma L.P. | Cyclic sulfonamides as sodium channel blockers |
EP3293184B1 (en) | 2013-03-04 | 2020-12-16 | Purdue Pharma L.P. | Pyrimidine carboxamides as sodium channel blockers |
US9120786B2 (en) | 2013-03-04 | 2015-09-01 | Purdue Pharma, L.P. | Triazine carboxamides as sodium channel blockers |
CA2939549C (en) | 2013-03-15 | 2020-08-18 | Purdue Pharma L.P. | Carboxamide derivatives and use thereof |
US9359330B2 (en) | 2013-08-26 | 2016-06-07 | Purdue Pharma L.P. | Substituted piperidines as sodium channel blockers |
EP3039019B1 (en) | 2013-08-26 | 2020-04-22 | Purdue Pharma L.P. | Azaspiro[4.5]decane derivatives and use thereof |
US9828348B2 (en) | 2013-11-08 | 2017-11-28 | Purdue Pharma L.P. | Benzimidazole derivatives and use thereof |
US9340504B2 (en) | 2013-11-21 | 2016-05-17 | Purdue Pharma L.P. | Pyridine and piperidine derivatives as novel sodium channel blockers |
WO2015094443A1 (en) * | 2013-12-20 | 2015-06-25 | Purdue Pharma L.P. | Pyrimidines and use thereof |
US9695144B2 (en) | 2013-12-23 | 2017-07-04 | Purdue Pharma L.P. | Dibenzazepine derivatives and use thereof |
CN106103415B (zh) | 2013-12-23 | 2023-02-24 | 普渡制药公司 | 吲唑和其用途 |
EP3089978B1 (en) | 2013-12-30 | 2018-08-29 | Purdue Pharma L.P. | Pyridone-sulfone morphinan analogs as opioid receptor ligands |
CN106061944A (zh) | 2014-01-24 | 2016-10-26 | 普渡制药公司 | 吡啶类和嘧啶类物质及其用途 |
CA2939501C (en) | 2014-02-12 | 2020-07-07 | Purdue Pharma L.P. | Isoquinoline derivatives and use thereof |
US10730866B2 (en) | 2014-04-07 | 2020-08-04 | Purdue Pharma L.P. | Indole derivatives and use thereof |
MA39956A (fr) | 2014-05-06 | 2015-11-12 | Purdue Pharma Lp | Analogues du benzomorphane et leur utilisation |
MA40170A (fr) | 2014-06-13 | 2017-04-19 | Purdue Pharma Lp | Dérivés hétérocycliques de morphinan et leur utilisation |
WO2015192053A1 (en) | 2014-06-13 | 2015-12-17 | Purdue Pharma L.P. | Azamophinan derivatives and use thereof |
BR112017017619A2 (pt) | 2015-02-19 | 2018-05-08 | Purdue Pharma Lp | métodos e composições para diminuir esvaziamento gástrico |
WO2018125716A1 (en) | 2017-01-02 | 2018-07-05 | Purdue Pharma L.P. | Morphinan derivatives and use thereof |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1122533B (de) * | 1959-04-18 | 1962-01-25 | Knoll Ag Chemischer Fabriken | Verfahren zur Herstellung basisch substituierter 4-Amino-6-hydroxypyrimidine |
MA18829A1 (fr) | 1979-05-18 | 1980-12-31 | Ciba Geigy Ag | Derives de la pyrimidine,procedes pour leur preparation,compositions pharmaceutiques contenant ces composes et leur utilisation therapeutique |
US4492792A (en) * | 1982-02-04 | 1985-01-08 | Ube Industries, Ltd. | Process for preparing 4-amino-5-dialkoxy-methylpyrimidine derivatives |
GB8909560D0 (en) * | 1989-04-26 | 1989-06-14 | Smith Kline French Lab | Chemical compounds |
AU8405991A (en) * | 1990-08-31 | 1992-03-30 | Nippon Shinyaku Co. Ltd. | Pyrimidine derivative and medicine |
DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
JPH0558997A (ja) | 1991-09-04 | 1993-03-09 | Mitsubishi Kasei Corp | チオカルバモイルアセトニトリル誘導体 |
US5232945A (en) * | 1992-07-20 | 1993-08-03 | Pfizer Inc. | 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives |
JP2789134B2 (ja) * | 1992-09-28 | 1998-08-20 | ファイザー・インク. | 糖尿病の合併症を制御する置換ピリミジン類 |
CA2147275A1 (en) | 1992-10-16 | 1994-04-28 | Hirokazu Yamada | Pyrimidine derivative |
CN1109687A (zh) | 1993-05-13 | 1995-10-04 | 日本钢管株式会社 | 嘧啶衍生物及医药组合物 |
GB2281295A (en) * | 1993-08-26 | 1995-03-01 | Zeneca Ltd | (2-Fluoroethyl) thio-substituted pyrimidines as nematicides |
US5569655A (en) * | 1993-09-14 | 1996-10-29 | Sterling Winthrop Inc. | Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof |
US5744492A (en) * | 1993-09-17 | 1998-04-28 | United States Of America | Method for inhibiting angiogenesis |
US5602156A (en) * | 1993-09-17 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Method for inhibiting metalloproteinase expression |
EP0724573A1 (en) | 1993-10-20 | 1996-08-07 | PHARMACIA & UPJOHN COMPANY | Pyrimidinones as antiarthritic and anti-inflammatories |
US5795905A (en) * | 1995-06-06 | 1998-08-18 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
US5874440A (en) * | 1995-06-07 | 1999-02-23 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives |
GB9525296D0 (en) * | 1995-12-11 | 1996-02-07 | Merck Sharp & Dohme | Therapeutic agents |
CZ302486B6 (cs) | 1998-06-02 | 2011-06-15 | Osi Pharmaceuticals, Inc. | N-6-Substituovaný 7-deazapurin, zpusob jeho prípravy a farmaceutická kompozice s jeho obsahem |
DE20080291U1 (de) * | 1999-03-26 | 2002-06-27 | Euro-Celtique S.A., Luxemburg/Luxembourg | Aryl-substituierte Pyrazole, Imidazole, Oxazola, Thiazole und Pyrrole |
CO5210940A1 (es) | 1999-05-04 | 2002-10-30 | Novartis Ag | Compuestos plaguicidas derivados de pirimidina y composiciones que los contienen |
WO2001010842A2 (en) | 1999-08-04 | 2001-02-15 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
DE19948434A1 (de) | 1999-10-08 | 2001-06-07 | Gruenenthal Gmbh | Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine |
EP1731520A1 (en) | 1999-12-02 | 2006-12-13 | OSI Pharmaceuticals, Inc. | Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3 |
AR029489A1 (es) * | 2000-03-10 | 2003-07-02 | Euro Celtique Sa | Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento |
EP1292577B1 (en) * | 2000-03-24 | 2012-10-24 | Euro-Celtique S.A. | Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker |
JP2003529589A (ja) * | 2000-03-31 | 2003-10-07 | ユーロ−セルティック エス. ア. | アミノピリジンならびにこれらの鎮痙薬およびナトリウムチャンネル遮断薬としての使用 |
JP2004538285A (ja) * | 2001-07-16 | 2004-12-24 | ユーロ−セルティック エス. ア. | アリール置換チアゾリジノンおよびその使用 |
AR037233A1 (es) * | 2001-09-07 | 2004-11-03 | Euro Celtique Sa | Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento |
AR036873A1 (es) * | 2001-09-07 | 2004-10-13 | Euro Celtique Sa | Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento |
-
2003
- 2003-03-13 JP JP2003574634A patent/JP4473583B2/ja not_active Expired - Fee Related
- 2003-03-13 IL IL16394003A patent/IL163940A0/xx unknown
- 2003-03-13 ES ES03719019T patent/ES2328471T3/es not_active Expired - Lifetime
- 2003-03-13 CN CNA038083833A patent/CN1646500A/zh active Pending
- 2003-03-13 US US10/386,483 patent/US7229993B2/en not_active Expired - Lifetime
- 2003-03-13 EA EA200401120A patent/EA200401120A1/ru unknown
- 2003-03-13 PT PT03719019T patent/PT1483247E/pt unknown
- 2003-03-13 AT AT03719019T patent/ATE434610T1/de active
- 2003-03-13 KR KR10-2004-7014305A patent/KR20040099324A/ko not_active Application Discontinuation
- 2003-03-13 BR BR0308451-5A patent/BR0308451A/pt not_active Application Discontinuation
- 2003-03-13 AP APAP/P/2004/003152A patent/AP2004003152A0/en unknown
- 2003-03-13 SI SI200331664T patent/SI1483247T1/sl unknown
- 2003-03-13 DK DK03719019T patent/DK1483247T3/da active
- 2003-03-13 CA CA002479036A patent/CA2479036A1/en not_active Abandoned
- 2003-03-13 MX MXPA04008901A patent/MXPA04008901A/es unknown
- 2003-03-13 AU AU2003223049A patent/AU2003223049A1/en not_active Abandoned
- 2003-03-13 DE DE60328087T patent/DE60328087D1/de not_active Expired - Lifetime
- 2003-03-13 WO PCT/IB2003/001837 patent/WO2003076414A2/en active Application Filing
- 2003-03-13 EP EP03719019A patent/EP1483247B1/en not_active Expired - Lifetime
-
2004
- 2004-09-10 TN TNP2004000174A patent/TNSN04174A1/en unknown
- 2004-09-24 IS IS7468A patent/IS7468A/is unknown
- 2004-10-11 MA MA27905A patent/MA27196A1/fr unknown
- 2004-10-12 CO CO04101907A patent/CO5611139A2/es not_active Application Discontinuation
- 2004-10-12 NO NO20044311A patent/NO20044311L/no unknown
- 2004-10-12 EC EC2004005360A patent/ECSP045360A/es unknown
- 2004-10-13 CR CR7526A patent/CR7526A/es not_active Application Discontinuation
-
2009
- 2009-09-10 CY CY20091100941T patent/CY1109355T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR20040099324A (ko) | 2004-11-26 |
DK1483247T3 (da) | 2009-08-17 |
ECSP045360A (es) | 2005-01-03 |
CR7526A (es) | 2008-08-12 |
US7229993B2 (en) | 2007-06-12 |
WO2003076414A2 (en) | 2003-09-18 |
EP1483247A2 (en) | 2004-12-08 |
BR0308451A (pt) | 2005-01-11 |
NO20044311L (no) | 2004-12-10 |
IS7468A (is) | 2004-09-24 |
ATE434610T1 (de) | 2009-07-15 |
CN1646500A (zh) | 2005-07-27 |
MXPA04008901A (es) | 2004-11-26 |
AP2004003152A0 (en) | 2004-12-31 |
US20030236273A1 (en) | 2003-12-25 |
DE60328087D1 (de) | 2009-08-06 |
SI1483247T1 (sl) | 2009-12-31 |
EP1483247B1 (en) | 2009-06-24 |
WO2003076414A3 (en) | 2003-12-24 |
PT1483247E (pt) | 2009-08-18 |
JP2005526069A (ja) | 2005-09-02 |
IL163940A0 (en) | 2005-12-18 |
CY1109355T1 (el) | 2014-07-02 |
CA2479036A1 (en) | 2003-09-18 |
EA200401120A1 (ru) | 2005-02-24 |
AU2003223049A1 (en) | 2003-09-22 |
JP4473583B2 (ja) | 2010-06-02 |
TNSN04174A1 (en) | 2007-03-12 |
MA27196A1 (fr) | 2005-01-03 |
ES2328471T3 (es) | 2009-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5611139A2 (es) | Pirimidinas aril sustituidas y el uso de las mismas | |
RS50537B (sr) | Derivati benzimidazola i njihovo korišćenje kao antagonista receptora a ii | |
CO5680403A2 (es) | Antagonistas de mchr1r | |
CO5590895A2 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
DE3467348D1 (de) | N-(2-nitrophenyl)-4-aminopyrimidine derivatives as microbicides | |
YU48390B (sh) | Novi derivati 2-anilinopirimidina, postupak za njihovo dobijanje i sredstva za uništavanje štetočina, koja sadrže ove derivate | |
CY1112914T1 (el) | Υποκατεστημενα παραγωγα ινδολυλ αλκυλ αμινης ως νεοι αναστολεις των αποακετυλασων ιστονης | |
ME01421B (me) | 5-supstituisani derivati kinazolinona kao protivtumorska sredstva | |
AR038536A1 (es) | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados | |
RS51674B (en) | PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS | |
NO20050871L (no) | 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer | |
CO5700777A2 (es) | Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de serotonina | |
AR040570A1 (es) | Deriados de acilaminotiazol, su preparacion y su aplicacion en terapeutica | |
DE602004014628D1 (de) | Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren | |
ES2177275T3 (es) | Derivados de oxadiazolina y su uso como insecticidas. | |
TW200517387A (en) | Compounds exhibiting thrombopoietin receptor agonism | |
EA200500298A1 (ru) | 2-аминобензотиазолсульфонамидные ингибиторы протеазы вич широкого спектра действия | |
ATE239722T1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
EA200700322A1 (ru) | Оксазолидиноны, содержащие оксиндолы, в качестве антибактериальных агентов | |
ATE399169T1 (de) | Imidazopyridinderivate als inhibitoren der induzierbaren no-synthase | |
BRPI0510075A (pt) | benzoxazocinas e seu uso terapêutico como inibidores de reabsorção de monoamina | |
ATE246703T1 (de) | Oral wirksame 7-alpha-alkyl androgene | |
DE3850222D1 (de) | 1,4-Disubstituierte-piperidinyl-Verbindungen. | |
AR023528A1 (es) | Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |